30-day FRN

37620

Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices

Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Innovative
Research in HIV in Kidney, Urology, and
Hematology.
Date: July 7, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–027:
Commercialization Readiness Pilot.
Date: July 8, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, cbackman@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–15–
315: CounterAct Exploratory Grants.
Date: July 8, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Baltimore, 2 North
Charles Street, Baltimore, MD 21201.
Contact Person: Geoffrey G Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: June 3, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13723 Filed 6–9–16; 8:45 am]
BILLING CODE 4140–01–P

amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, COBRE Phase I.
Date: July 15, 2016.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Nina Sidorova, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.22, Bethesda, MD
20892–6200, 301–594–3663, sidorova@
nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research, Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: June 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13727 Filed 6–9–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: Autism Spectrum
Disorder (ASD) Research Portfolio
Analysis, NIMH
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute of Mental Health, the National
Institutes of Health, has submitted to the
Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in

asabaliauskas on DSK3SPTVN1PROD with NOTICES

SUMMARY:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as

VerDate Sep<11>2014

19:02 Jun 09, 2016

Jkt 238001

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

the Federal Register on March 23, 2016,
Vol. 81 page 15541 and allowed 60-days
for public comment. One public
comment was received, requesting a
copy of the data collection plans and
instruments; the NIMH Office of Autism
Research Coordination provided draft
copies of the data collection plan and
instrument to the requester. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute of Mental Health
(NIMH), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: The Office of Autism Research
Coordination, NIMH, NIH, Neuroscience
Center, 6001 Executive Blvd., MSC
9663, Room 6184, Bethesda, Maryland
20892. Or you can Email your request,
including your address to:
[email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: NIMH Office of
Autism Research Coordination (OARC)
Autism Spectrum Disorder (ASD)
Research Portfolio Analysis, 0925–0682,
Expiration Date 09/30/2016—
EXTENSION, National Institute of
Mental Health (NIMH), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of the ASD
portfolio analysis is to collect research
funding data from U.S. and
international ASD research funders, to
assist the Interagency Autism
Coordinating Committee (IACC) in
fulfilling the requirements of the
Combating Autism Act, and to inform
the committee and interested
stakeholders of the funding landscape

E:\FR\FM\10JNN1.SGM

10JNN1

37621

Federal Register / Vol. 81, No. 112 / Friday, June 10, 2016 / Notices
and current directions for ASD research.
Specifically, these analyses will
continue to examine the extent to which
current funding and research topics
align with the IACC Strategic Plan for
ASD Research. The findings will help

guide future funding priorities by
outlining current gaps and opportunities
in ASD research as well as serving to
highlight annual activities and research
progress.

OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
520.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
(funders)

Number of
respondents

U.S. Federal .....................................................................................................
U.S. Private ......................................................................................................
International Government ................................................................................
International Private .........................................................................................

22
8
4
4

(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

Dated: June 3, 2016.
Melba Rojas,
Project Clearance Liaison, NIMH, NIH.
[FR Doc. 2016–13722 Filed 6–9–16; 8:45 am]
BILLING CODE 4140–01–P

Dated: June 6, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2016–13726 Filed 6–9–16; 8:45 am]

National Institutes of Health

BILLING CODE 4140–01–P

National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13/U13).
Date: June 28–30, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Actives,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
[email protected].

VerDate Sep<11>2014

19:02 Jun 09, 2016

Jkt 238001

Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting

Frm 00056

Fmt 4703

Sfmt 4703

Average time
per response
(in hours)

63
75
14
9

Total burden
hours

15/60
15/60
15/60
15/60

347
150
14
9

Designated Federal Officer; Tracy Goss
(see contact information below).
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: June 29, 2016, 2:30
p.m.–3:30 p.m. EDT, CLOSED.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
Telephone: (240) 276–0759, Fax: (240)
276–2252, Email: tracy.goss@
samhsa.hhs.gov.
Summer King,
Statistician, SAMHSA.
[FR Doc. 2016–13690 Filed 6–9–16; 8:45 am]
BILLING CODE 4162–20–P

Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA’s)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council will
meet on June 29, 2016, 2:30 p.m.–3:30
p.m. (EDT) in a closed teleconference
meeting.
The meeting will include discussions
and evaluations of grant applications
reviewed by SAMHSA’s Initial Review
Groups, and involve an examination of
confidential financial and business
information as well as personal
information concerning the applicants.
Therefore, the meeting will be closed to
the public as determined by the
Principal Deputy SAMHSA
Administrator, in accordance with Title
5 U.S.C. 552b(c)(4), (6)(B) and Title 5
U.S.C. App. 2, Section 10(d).
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee Web
site at http://www.samhsa.gov/about-us/
advisory-councils/csat-nationaladvisory-council or by contacting the
CSAT National Advisory Council

PO 00000

Number of
projects per
respondent

DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2016–0002; Internal
Agency Docket No. FEMA–B–1628]

Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:

This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each

SUMMARY:

E:\FR\FM\10JNN1.SGM

10JNN1